Manulife (Manufacturers Life Insurance)’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
VCM
VPM
Manulife (Manufacturers Life Insurance)'s ADPT Position: Q1 2026 in Review
Manulife (Manufacturers Life Insurance) reduced its Adaptive Biotechnologies (ADPT) stake by 2% in Q1 2026, selling an estimated $23.1K and leaving 71,672 shares worth $995K. The position accounts for ﹤0.01% of the portfolio, ranked #1833.
Manulife (Manufacturers Life Insurance) first reported a position in ADPT in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.19M in Q4 2025. 296 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.
- Manulife (Manufacturers Life Insurance) held 71,672 shares of Adaptive Biotechnologies worth $995K as of Q1 2026.
- Manulife (Manufacturers Life Insurance) sold 1,448 Adaptive Biotechnologies shares in Q1 2026, an estimated $23.1K.
- Adaptive Biotechnologies made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1833 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in Adaptive Biotechnologies in Q1 2022 and has held it in 17 quarters since.
- Manulife (Manufacturers Life Insurance)'s Adaptive Biotechnologies position peaked at $1.19M in Q4 2025.
- 296 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.